An Omalizumab Biobetter Antibody With Improved Stability and Efficacy for the Treatment of Allergic Diseases.

Saved in:
Bibliographic Details
Title: An Omalizumab Biobetter Antibody With Improved Stability and Efficacy for the Treatment of Allergic Diseases.
Authors: Liu P; Department of Biological Medicines & Shanghai Engineering Research Center of Immunotherapeutics, Fudan University School of Pharmacy, Shanghai, China.; Shanghai Jemincare Pharmaceuticals Co., Ltd., Shanghai, China., Pan Z; Shanghai Jemincare Pharmaceuticals Co., Ltd., Shanghai, China., Gu C; Shanghai Jemincare Pharmaceuticals Co., Ltd., Shanghai, China., Cao X; Shanghai Jemincare Pharmaceuticals Co., Ltd., Shanghai, China., Liu X; Shanghai Jemincare Pharmaceuticals Co., Ltd., Shanghai, China., Zhang J; Shanghai Jemincare Pharmaceuticals Co., Ltd., Shanghai, China., Xiao Z; Shanghai Jemincare Pharmaceuticals Co., Ltd., Shanghai, China., Wang X; Shanghai Jemincare Pharmaceuticals Co., Ltd., Shanghai, China., Guo H; Shanghai Jemincare Pharmaceuticals Co., Ltd., Shanghai, China., Ju D; Department of Biological Medicines & Shanghai Engineering Research Center of Immunotherapeutics, Fudan University School of Pharmacy, Shanghai, China., Deng SJ; Shanghai Jemincare Pharmaceuticals Co., Ltd., Shanghai, China.
Source: Frontiers in immunology [Front Immunol] 2020 Nov 27; Vol. 11, pp. 596908. Date of Electronic Publication: 2020 Nov 27 (Print Publication: 2020).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1664-3224
DOI:10.3389/fimmu.2020.596908